Activation of phosphatidylinositol 3 kinase (PI3K), Ras, and Her2 signaling plays a critical role in cancer development. Hotspot constitutive activating mutations in oncogenes, such as PIK3CA encoding the p110α catalytic subunit or RAS, as well as overexpression of Her2, are frequently found in human tumors and cancers. It has been well established that activation of these oncogenes profoundly promotes tumor metastasis, whereas decreased expression of ΔNp63α, the major protein isoform of the p53-related p63 expressed in epithelial cells, has been associated with cancer metastasis. In this study, we demonstrate that hotspot oncogenic mutations on PIK3CA and RAS, including p110α H1047R , K-Ras G12V , and H-Ras G12V , as well as activation of Her2, all led to suppression of ΔNp63α expression via Akt-fork-head transcription factor 3a (Akt-FOXO3a) signaling, resulting in increased cell motility and tumor metastasis. Expression of ΔNp63α effectively reversed p110α
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PIK3CA | Ras | Her2 | ΔNp63α | cancer metastasis P hosphatidylinositol 3-kinases (PI3Ks) are a family of lipid kinases that play a critical role in regulation of cell proliferation, survival, motility differentiation, adhesion, cytoskeletal rearrangement, and intracellular trafficking (1) . PI3Ks are categorized into four families according to their subunit structure, regulation, and substrate selectivity (2) . Class IA PI3Ks are heterodimers consisting of a catalytic p110 subunit (p110α, p110β,or p110γ, encoded by PIK3CA, PIK3CB, and PIK3CD, respectively) and a regulatory p85 subunit (p85α, p55α, p50α, p85β, and p55γ). In mammalian cells, the p110α and p110β isoforms are expressed ubiquitously, whereas p110γ expression is restricted to immune cells (1, 3, 4) . Aberrant PI3K signaling is frequently found in human cancers, either as a consequence of receptor tyrosine kinase mutation or amplification, loss, or inactivation of the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor suppressor, or by gain-of-function or amplification of PI3K genes (5) (6) (7) (8) (9) . The oncogenic hotspot mutations of PIK3CA are found within the p110α helical domain (E545K and E542K) or the kinase domain (H1047R). In particular, the hotspot mutation p110α H1047R is found in over 30% of breast cancers, 20% of colorectal cancers, head and neck cancers, and gastric cancers, and 15% of lung cancers (10) (11) (12) (13) (14) . p110α H1047R exhibits elevated kinase activity and can potently promote cellular transformation and tumorigenesis in mouse xenograft and genetic models (15) (16) (17) (18) (19) .
Active PI3Ks phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) at the 3-position of the inositol ring, converting it to phosphatidyl inositol 3,4,5-triphosphate (PIP3). PIP3 acts as a docking site for pleckstrin homology (PH)-containing proteins, including Akt/PKB, PDK1, and Btk1 (20) . Once at the membrane, Akt is activated by PDK1, which in turn phosphorylates downstream protein targets, including a subset of fork-head transcription factors (FOXO), TSC2, mammalian target of rapamycin (mTOR), IKK, and GSK3β (21) . Activation of Akt signaling is pivotal in cell proliferation, survival, and motility (22) .
Two members of FOXO family, FKHR (FOXO1) and FKHRL1 (FOXO3a), regulate expression of specific sets of genes involved in variety of biological processes. FOXO1 plays important roles in regulation of gluconeogenesis and glycogenolysis via insulin signaling, and is also critical for adipogenesis. FOXO3a plays an important role in regulation of apoptosis, notch signaling, stem cell self-renewal, stress resistance, and longevity (23) (24) (25) (26) . Down-regulation of FOXO3a is associated with cancer development (23) .
The Ras superfamily of small GTPase functions as molecular switches, relaying signals from cell surface receptors to intracellular kinase cascades, which is pivotal in regulating many biological processes (27) . Activated Ras transduces signals to downstream effectors, including Raf, PI3K, Ral, and Rac, which promote cell proliferation, survival, motility, and tumor metastasis (28) (29) (30) . There Significance Oncogenic hotspot mutations in PIK3CA or RAS and overexpression of Her2 are known as a driving force for human cancer development. We and others have shown that ΔNp63α, the major protein isoform of the p53-related p63 expressed in epithelial cells, functions as an important regulator for the cell adhesion program and is a critical inhibitor of cancer metastasis. In this study, we demonstrate that oncogenic p110α
, and Her2 use a common Akt1-FOXO3a pathway in suppression of ΔNp63α expression and, consequently, promote cell migration/invasion and tumor metastasis. Thus, ΔNp63α may function as a critical integrator of oncogenic signals in cell motility and cancer metastasis.
are three Ras isoforms: K-Ras, H-Ras, and N-Ras. Somatic K-Ras mutations are frequently found in human cancers, including in over 90% pancreas cancers, ∼50% colorectal cancers, and 40% lung cancers (6, 11, 31) , whereas mutations in H-Ras gene are found in about 15% bladder cancers, 6-12% head and neck cancers, and 4% lung cancers (12, 14, 32, 33) . Among these mutations, a single amino acid substitution mutation at codon 12 (including G12V) prevails in most tumors, which produces constitutive activation of Ras (34) .
Her2 is a member of the human epidermal growth factor receptor (HER/EGFR/ERBB) family, interacting with other ErbB receptors to form heterodimers, resulting in the autophosphorylation of tyrosine residues within the cytoplasmic domain of the receptors, which initiates a variety of signaling pathways, including mitogen-activated protein kinase (MAPK), PI3K/Akt, phospholipase Cγ (PLCγ), protein kinase C (PKC), and signal transducer and activator of transcription (STAT) (35, 36) . Overexpression of Her2 is found in 22% of breast cancers, 28% of pulmonary adenocarcinoma, 17% of colorectal adenocarcinomas, 11% of pulmonary squamous, and 11% of gastric adenocarcinomas (37) . Her2 overexpression is also found in ovarian and aggressive forms of uterine cancer (38) (39) (40) . Recent evidence has implicated Her2 signaling in resistance to the EGFR-targeted cancer drug cetuximab (41) .
p63 is a p53 family member that plays a pivotal role in a wide range of biological processes, including cell proliferation, survival, apoptosis, differentiation, cell migration and invasion, and senescence. Because of an alternative transcription start site, the p63 is expressed as either TAp63 isoforms containing a N-terminal transactivation (TA) domain homologous to that of p53, or ΔNp63 proteins that lack this domain and possess instead a shorter and unique N-terminal TA domain. Alternative splicing at the C terminus generates five different C termini (α, β, γ, δ, and e), for a total of over 10 p63 protein isoforms (42, 43) . TAp63 and ΔNp63 play unique and overlapping roles in cancer development. It has been shown that both TAp63 and ΔNp63 proteins are important metastasis inhibitors. Mice with a deleted TAp63 gene develop highly metastatic carcinomas and sarcomas (44) , whereas silencing endogenous ΔNp63α promotes metastasis of Her2/ Neu-transformed mammary epithelial cells (45) .
In this study, we demonstrate that the hotspot mutation of PI3KCA, p110α H1047R , dramatically inhibited ΔNp63α expression, resulting in elevated cell motility and tumor metastasis in animal models. Strikingly, K-Ras G12V , H-Ras G12V , and activation of Her2, all led to down-regulation of ΔNp63α expression, and consequently increased cell migration, invasion, and tumor metastasis. We show that ΔNp63α was a direct FOXO3a transcriptional target, and that FOXO3a-mediated regulation of ΔNp63α was critical in p110α H1047R -, K-Ras
G12V
-, H-Ras G12V -, or Her2-mediated cell motility. Moreover, we found a clear clinical correlation between FOXO3a and ΔNp63α expression in human lung and breast cancer clinical samples. Together, these results indicate that ΔNp63α is a common target of oncogenic PI3K, Ras, and Her2, and that ΔNp63α may function as a critical integrator of oncogenic signals in cancer metastasis.
Results

p110α
H1047R Induces Scattered Cell Growth, Cell Migration, and Invasion.
Activation of PI3K is critical in tumorigenesis and cancer development. Hotspot mutations in the PIK3CA, which encodes catalytic subunit p110α-in particular, H1047R-have been frequently found in advanced human cancers (46) . Thus, we investigated the effects of p110α H1047R on cell migration and invasion. We first examined the effect of p110α H1047R on morphology of human nontransformed mammary epithelial MCF-10A cells. As shown in -expressing cells completely reverted cell migration and invasion back to levels comparable to control cells ( Fig. 1 B-D) .
We then examined whether expression of p110α H1047R can affect the motility of other cell types in addition to MCF-10A. As shown in Fig. S1 , expression of p110α H1047R evidently promoted scattered cell growth and increased cell migration/invasion in both human head and neck squamous cell carcinoma FaDu cells and immortalized human keratinocyte HaCaT cells (Fig. S1 B-D).
K-Ras
G12V and H-Ras G12V Potently Induce Scattered Cell Growth, Cell
Migration, and Invasion. Activated Ras plays a critical role in tumorigenesis. We therefore examined the effect of K-Ras
G12V
and H-Ras G12V on cell morphology, cell migration, and invasion. As shown in Figs. 1 E-G, expression of K-Ras G12V or H-Ras G12V led to scattered cell growth and increased cell migration and invasion. These results indicate that activation of PI3K and Ras signaling promotes cell motility in vitro. (E) Stable cells were infected with lentivirus expressing either of two different shRNAs specific for Akt1 (shAkt1-1 and shAkt1-2), or a control shRNA (shC), followed by Western blotting analyses. (F) Stable cells were infected with lentivirus expressing shAkt1-1 or shC, followed by transwell assays. Data are means and SEs from three independent experiments; *P < 0.05; **P < 0.01; ***P < 0.001; N.S., not significant.
we investigated the effect of these oncogenes on ΔNp63α expression. As shown in Fig. 2A, expression , or H-Ras G12V inhibits ΔNp63α expression, we first used pharmacological inhibitors, including SB203580 (p38 inhibitor), PD98059 (Mek-Erk1/2 inhibitor), and Wortmannin (PI3K-Akt inhibitor). As shown in Fig. S2B, SB203580 and PD98059 treatment led to a clear inhibition of p-p38 or p-Erk, respectively, yet neither had effects on ΔNp63α expression that were inhibited by p110α
, or H-Ras G12V . In contrast, inhibition of PI3K by Wortmannin clearly rescued ΔNp63α expression (Fig. 2B) .
Evidently, p110α H1047R , K-Ras G12V , or H-Ras G12V strongly promoted cell migration, which was effectively inhibited by PI3K inhibitor Wortmannin, but not by p38 inhibitor SB203580 (Fig.  2C and Fig. S2C ). Inhibition of Erk by PD98059 led to a clear suppression of cell migration, albeit to a much lesser extent than Wortmannin ( Fig. 2C and Fig. S2C ). These results indicate that PI3K signaling is critical for these oncogene-mediated ΔNp63α down-regulation and enhanced cell migration.
Because Akt is a major effector of PI3K signaling, we directly examined the role of Akt activation in ΔNp63α down-regulation. MK-2206, a potent Akt inhibitor, indeed inhibited Akt activation. At the same time, it completely reversed ΔNp63α protein expression, which was suppressed by p110α H1047R , K-Ras G12V , or H-Ras G12V . In addition, MK-2206 could also largely reversed expression of DPL and Par3, but not E-cad (Fig. 2D) .
It has been reported that MK-2206 inhibits Akt1 much more effectively than Akt2 and Akt3 (50, 51); we therefore examined the effects of silencing of Akt1 on ΔNp63α protein expression. As shown in Fig. 2E , although shAkt1-1 exhibited excellent efficacy in silencing Akt1, shAkt1-2 did not silence Akt1 well. Indeed, shAkt1-1 completely reversed ΔNp63α protein expression. In contrast, shAkt1-2 failed to reverse ΔNp63α protein expression.
Similarly, silencing of Akt1 effectively prevented cell migration and invasion induced by p110α H1047R , K-Ras
, or H-Ras G12V ( Fig. 2F and Fig. S2D ). Together, these results demonstrate that PI3K-Akt1 is critically important in p110α , or H-Ras G12V inhibits ΔNp63α expression via Akt1, suggesting a role for ΔNp63α in these oncogene-induced cell motility. Indeed, ectopic expression , or a vector (V) were infected with lentivirus expressing ΔNp63α or vector control (Con), and selected for drug-resistance, then subjected to (A) Western blotting analyses, (B) cell morphology assays, and (C) transwell assays. (Scale bars, 100 μm.) Data are means and SEs from three independent experiments; **P < 0.01.
of ΔNp63α significantly inhibited cell migration and invasion (Fig.  S3A) . To directly investigate the role of ΔNp63α down-regulation in p110α
-induced cell motility, we performed rescuing experiments. As shown in Fig. 3 , restoration of ΔNp63α significantly reversed cell spreading, dispersion, cell migration, and invasion ( Fig. 3 A-C and Fig. S3 B and C) . Similar reversing effects on cell motility via restoration of ΔNp63α were observed in FaDu or HaCaT cells stably expressing p110α H1047R (Fig. S3 D-F) .
H1047R , K-Ras G12V , or H-Ras G12V , overexpression of Her2 significantly induced cell migration and invasion in MCF-10A cells (Fig. 4A) , concomitant with down-regulation of ΔNp63α (Fig. 4B) . To examine whether Akt signaling is involved in Her2-induced ΔNp63α down-regulation and cell migration/invasion, we used several independent assays. First, LY294002 or Wortmannin, two chemical inhibitors of PI3K/Akt, completely blocked Her2-mediated down-regulation of ΔNp63α (Fig. 4B) . Ablation of Akt1 by two independent shRNA constructs effectively led to reversed expression of ΔNp63α and inhibition of cell motility induced by Her2 (Fig. 4 C and D) . Restoration of ΔNp63α partially rescued Her2-induced cell migration and invasion (Fig. 4E) . Together, these results indicate that Her2-induced ΔNp63α down-regulation and increased cell motility is through Akt signaling. Thus, oncoproteins, including p110α H1047R , K-Ras G12V , H-Ras
, and Her2, all target ΔNp63α to promote cell motility. , or Her2 Inhibits ΔNp63α Expression via Suppression of FOXO3a. We then investigated the molecular mechanisms by which oncogenic signaling down-regulates ΔNp63α. As shown in Fig. 5A , expression of p110α H1047R , K-Ras G12V , H-Ras G12V , or Her2 dramatically down-regulated steady-state ΔNp63α mRNA levels. In contrast, p110α H1047R , K-Ras G12V , or H-Ras G12V had no significant impact on ΔNp63α protein stability (Fig. S4A) . Together, these results indicate that ΔNp63α is regulated most likely at the transcriptional levels.
It is well documented that Akt regulates multiple transcription factors by phosphorylation. In particular, Akt directly phosphorylates and inhibits nuclear translocation as well as transactivation activity of the FOXO family of proteins, including FOXO3a (also known as FKHRL1) and FOXO1 (also known as FKHR), which have been shown to play a role in regulating cell migration and invasion (53, 54) . We investigated whether FOXO transcription factors are involved in regulation of ΔNp63α expression. Knockdown of FOXO3a, but not FOXO1, led to significant decrease in both protein and mRNA levels of ΔNp63α in MCF-10A or FaDu cells (Fig. S4B) . Furthermore, expression of p110α H1047R , K-Ras G12V , H-Ras G12V , or Her2 led to a significantly increase in FOXO3a phosphorylation (Fig. 5B) , concomitant with decreased ΔNp63α protein levels.
To investigate the role of FOXO3a in ΔNp63α expression regulated by p110α H1047R , K-Ras G12V , H-Ras G12V , or Her2, we knocked down FOXO3a by two different shRNA (sh3a-1 and sh3a-2) in MCF-10A, FaDu, or HaCaT cells. As shown in Fig. 5C and Fig. S4C , knockdown of FOXO3a led to significantly reduced ΔNp63α mRNA and protein levels, and a markedly increase in cell migration/invasion (Fig. 5D and Fig. S4D ), which was completely rescued by restoration of ΔNp63α expression ( Fig. 5E and Fig. S4E ). Conversely, ectopic expression of GFPtagged FOXO3a (GFP-FOX3a) up-regulated ΔNp63α expression, resulting in decreased cell migration/invasion, which was effectively rescued by knockdown of ΔNp63α using two different shRNAs specific for p63 (Fig. 5F ). -1 and shAkt1-2) , or a control shRNA (shC), followed by Western blotting analyses (C) and transwell assays (D). (E) MCF-10A stable cells expressing Her2 or vector (V) were infected with lentivirus expressing ΔNp63α or vector control (Con), followed by Western blotting analyses and transwell assays. Data were means and SEs from three independent experiments; **P < 0.01. -1 and sh3a-2) , or a control shRNA (shC), followed by qPCR, Western blotting analyses (C), and transwell assays (D). (E) MCF-10A cells stably expressing sh3a-1 were infected with lentivirus expressing ΔNp63α, or vector control (Con), followed by Western blotting analyses (Upper) and transwell assays (Lower). (F) MCF-10A cells stably expressing GFP-FOXO3a were infected with lentivirus expressing either of two different shRNAs for p63 (shp63-1 or shp63-2) or a control shRNA (shC), followed by Western blotting analyses and transwell assays. (G) MCF-10A stable cell expressing p110α H1047R , K-Ras G12V , H-Ras G12V , Her2, or a vector control (V) were infected with lentivirus expressing WT FOXO3a (3a-WT) or FOXO3a with triple-phospho mutant (T32A; S253A; S315A) (3a-TM), followed by Western blotting analyses. (H) Two putative FOXO3a-binding elements (P1: −650 to −639; P2: +998 to +1011) on ΔNp63 gene promoter and FOXO3a-binding consensus sequence are depicted (Upper); the P1 and P2 sequences of p63 gene in five species were aligned (Lower). (I) ChIP analyses were performed in HaCaT cells using a specific FOXO3a antibody or a control mouse normal IgG and primers specific for P1 and P2; a randomly chosen segment (−469 to −362) was used as control (Con). (J) qPCR analyses of ChIP samples derived from I were performed. Cp value of each ChIP sample was normalized to its corresponding input. The normalized value of P1 from the ChIP-qPCR was arbitrarily set as 1.0. Data are means and SEs from three independent experiments; **P < 0.01.
To further investigate the role of FOXO3a in ΔNp63α expression, we used WT FOXO3a (FOXO3a-WT) or a triple mutant FOXO3a (FOXO3a-TM), which bears serine-to-alanine mutations on three Akt phosphorylation sites (T32, S253, S315). FOXO3a-TM is resistant to Akt phosphorylation and thus acts as a constitutively active transactivation factor (55) . As shown in Fig. 5G , ectopic expression of FOXO3a-TM not only completely reverted p110α
-, or Her2-mediated suppression of ΔNp63α expression, but also oncogene-induced cell motility (Fig. S4F) . In contrast, WT FOXO3a had little effects on ΔNp63α expression, nor on cell motility induced by those oncogenes (Fig. S4F) . Together, these results demonstrate that PI3K, Ras, or Her2 oncoproteins induce cell motility via Akt1-mediated inhibition of FOXO3a and, consequently, suppression of ΔNp63α expression.
ΔNp63α Is a Direct FOXO3a Transcriptional Target. To further investigate the molecular mechanisms involved in FOXO3a-mediated ΔNp63α regulation, we examined whether FOXO3a directly regulates ΔNp63α expression. As shown in Fig. 5H , computational analysis of the TP63 promoter sequence by the TRANSFAC software revealed two putative FOXO3a binding sites. The first site (P1; −650 to −639 relative to the ΔNp63 transcriptional start site) and the second site (P2; +998 to +1011) contain sequences that match to the consensus sequence of FOXO3a binding sites (TTGTTTTC) (56) and to the documented FOXO3a binding site on the p27 kip1 promoter (57) . In addition, P1 is highly conserved in fivevertebrate species, whereas P2 is conserved in four mammalian species (Fig. 5H) . Data from ChIP experiments showed that P1 and P2 were FOXO3a-binding sites (Fig. 5I) , and the strength for FOXO3a binding to P1 was comparable to that of p27 kip1 (Fig. 5J ). These results demonstrate that FOXO3a likely exerts direct transcriptional regulation on ΔNp63α.
Down-Regulation of
To investigate the pathological role of PI3K, Ras, and Her2 oncoproteins in animal models, we chose to examine the role of ΔNp63α in p110α H1047R -, KRas G12V -, or Her2-induced tumor metastasis in vivo. To this end, we intravenously injected stable MCF-10A cells expressing p110α H1047R , K-Ras G12V , or Her2 with or without ectopic ΔNp63α expression into the tail veins of recipient nude mice. Although no single metastatic nodule was observed from mice bearing control cells (Fig. 6), mice bearing p110α H1047R -or Her2-expressing cells exhibited multiple metastatic nodules on the lung surface, and many more metastatic nodules were observed on the lung surface of mice bearing K-Ras G12V -expressing cells. In addition, many metastatic nodules derived from K-Ras G12V -expressing cells were much larger than that from p110α H1047R -or Her2-expressing cells. Expression of ΔNp63α effectively suppressed the formation of metastatic nodules induced by p110α H1047R , K-Ras G12V , or Her2 (Fig. 6 A and B) . Histological examination revealed normal lung architecture in control mice, whereas lungs from mice bearing p110α H1047R -, K-Ras G12V -, or Her2-expressing cells exhibited significant infiltration of metastatic cells (Fig. 6C) . Restoration of ΔNp63α expression completely reversed lung architecture back to normal (Fig. 6C) . Taken together, these results demonstrate the importance of ΔNp63α in oncogenic PI3K-, Ras-, or Her2-induced tumor metastasis in vivo.
Down-Regulation of FOXO3 and p63 Suppression Is Correlated in Lung
and Breast Cancer. To examine the clinical relevance of p63 downregulation in human cancer development, we analyzed correlation of p63 expression using TCGA database. As shown in Fig. 7A , G12V mutation of KRAS significantly (P = 0.0158) correlated with reduced p63 expression in lung adenocarcinoma (Fig. 7A, Left) . p63 mRNA expression was also significantly (P = 0.0005) reduced in Her2
+ invasive ductal breast carcinoma compared with Her2 − invasive ductal breast carcinoma (Fig. 7A, Center) . In addition, in human Her2 − invasive breast carcinoma samples, PIK3CA H1047R mutation correlated (P = 0.0155) with reduced p63 expression (Fig. 7A, Right) . Thus, these data reveal a close correlation between down-regulation of p63 and expression of oncogene PIK3CA, RAS, or HER2 in advanced human cancers.
To examine the clinical relevance of the FOXO3a-p63 axis in human cancer development, we analyzed p63 and FOXO3a expression in human tumor biopsy samples. As shown in Fig. 7B , Oncomine analyses showed a significant decrease in expression of both FOXO3a and p63 in invasive ductal breast carcinoma, compared with normal breast tissue. Further analyses revealed a significant positive relationship between FOXO3a and p63 expression (R = 0.468; P = 0.002) (Fig.  7C) . These results suggest that reduced FOXO3a and p63 mRNA expression are correlated with human cancer development.
We further performed immunohistochemical (IHC) analyses of human lung adenosquamous carcinoma biopsy samples (n = 83) and scored for FOXO3a and p63 protein levels. As shown in Fig. 7D , low expression of FOXO3a was found in 51.8% of all samples (43 of 83). Low expression of p63 was found in 43.4% of all samples (36 of 83). Notably, tumors containing higher levels of FOXO3a often exhibited higher levels of p63 (33 of 40), whereas tumors expressing lower levels of FOXO3a often exhibited lower levels of p63 (29 of 43) . Statistical analyses showed a significant positive correlation between FOXO3a and p63 expression (R = 0.504; P < 0.01). Because FOXO3a is critically regulated at the level of protein phosphorylation for its subcellular localization and consequent transactivation activity, we therefore investigated the protein levels of phosphorylated FOXO3a (p-FOXO3a) and p63 in human lung squamous carcinoma biopsy samples (n = 92) by IHC analyses. As shown in Fig. 7E , pFOXO3a was readily detectable in cytoplasm and accounted for 52.2% (48 of 92). Low expression of p63 was about 47.8% (44 of 92). Importantly, tumors expressing lower levels of p-FOXO3 in the cytosol (n = 48) often exhibited high levels of nuclear p63 (n = 34), whereas tumors with higher levels of p-FOXO3a (n = 44) in the cytosol often exhibited low levels of nuclear p63 (n = 28). Statistical analyses found a significant negative correlation between p-FOXO3a and p63 expression (R = −0.687; P < 0.01). Taken together, these results indicate that FOXO3a phosphorylation is most likely responsible for reduced p63 expression in human lung squamous carcinoma.
Discussion
Tumor-suppressor protein p53-related p63 plays pivotal role a wide range of biological processes, including cell proliferation, survival, apoptosis, differentiation, cell migration and invasion, and senescence. Accumulating evidence indicates that decreased ΔNp63α expression may play a causative role in promoting cell motility and cancer metastasis (42, (58) (59) (60) . In this study, we show that activation of three cancer signaling pathways, including PI3K, Ras, and Her2 signaling, promotes cancer cell motility and tumor metastasis by commonly targeting and repressing ΔNp63α expression. First, expression of either p110α H1047R , K-Ras G12V , H-Ras G12V , or Her2 significantly inhibits ΔNp63α expression. , and H-Ras G12V dramatically suppress p63 expression and, consequently, inhibition of DPL and E-cad. However, restoration of ΔNp63α is unable to reverse expression of E-cad, which likely attributes to the observed incomplete rescue of H1047R-induced cell motility. It is plausible that other proteins/effectors might be responsible for PI3K signaling on migration.
Abnormally activated PI3K signaling promotes cancer progression via multiple pathways, including Akt-FOXO, Akt-TSC2, Akt-mTOR, Akt-IKK, and Akt-GSK3β (21) . It has been reported that PI3KCA hotspot mutations, H1047R and E545K, promote colorectal cancer cell survival via Akt-mediated inhibition of FOXO1 and FOXO3a, but not by other Akt targets, such as mTOR, 4E-BP1, p70-S6K, TSC2, GSK3β, and AFX (61) . In this study, we show that FOXO3a, but not FOXO1, is responsible for p110α H1047R -, K-Ras G12V -, H-Ras G12V -, and Her2-mediated suppression of ΔNp63α expression. In fact, FOXO3a has been implicated in metastasis inhibition. For example, it has been shown that silencing FOXO3a in urothelial cells leads to increased cell motility, and that decreased FOXO3a expression is indicative of poor prognosis in patients with urothelial carcinomas (53) . Similarly, ΔNp63α ablation in urothelial carcinoma cells results in increased cell motility (62) . Moreover, bladder carcinomas that progress to muscle-invasive disease typically exhibit loss of ΔNp63α expression (62) . In keeping with these observations, our analysis of clinical biopsy samples indicated that both p63 and FOXO3 are downregulated in invasive breast cancer cases, and in lung cancers. Interestingly, in contrast to our findings in this study, ΔNp63α was reported to be positively regulated by PI3K signaling in keratinocytes (63) , and by the EGF receptor in squamous cell carcinoma cells (64) . Notably, up-regulation of ΔNp63α has been implicated in promoting tumor metastasis in several settings (58) (59) (60) . These inconsistencies may reflect differences between oncogenic and normal physiological signaling, depending on the cellular context. Multiple mechanisms have been described to explain how ΔNp63α inhibits cell motility and cancer metastasis. It has been shown that ΔNp63α is involved in transcriptional activation of adhesion proteins, including integrin α6, integrin β4, E-cad, and fibronectin and DPL (49) . We previously showed that ΔNp63α inhibits cancer cell migration, invasion, and metastasis by upregulating expression of the metastasis suppressor CD82, a member of the tetraspanin family of proteins (47) , as well as MAP kinase phosphatase 3 (MKP3), which negatively regulates Erk2 signaling to inhibit cancer cell migration, invasion, and metastasis (45) . In addition, ΔNp63α has been shown to regulate N-cadherin, L1 adhesion molecule, and Wnt-5A, which play a role in regulating cell migration (65) , and to repress cell invasion by inhibiting Ets-1-mediated matrix metallopeptidase 2 (MMP2) expression via Id-3 up-regulation (66) . Hence, ΔNp63α may act as a master regulator in regulation of cell motility.
It is striking that oncogenic p110α H1047R , Ras, and Her2 all target and suppress ΔNp63α expression. Hence, it is possible that ΔNp63α may function as an integrator for oncogenic signals that impact cell motility and cancer metastasis (Fig. 7F) . This notion is consistent with a recent study showing that RAS and PIK3CA oncogenes induce epithelial-mesenchymal transition through down-regulation of ΔNp63α (67) and with several studies implicating a role of ΔNp63α in epithelial-mesenchymal transition and cancer metastasis (68) (69) (70) . Given that p53 functions as an integrator for cellular stress, including DNA damage, hypoxia, nutrient deprivation, and oxidative stress (71) , it is plausible that p53 and p63 are safe guardians against stress signals that impact cell transformation and cancer metastasis.
Materials and Methods
